(Q38298524)

1 September 2017

1 reference

7 August 2019

The promise of novel molecular markers in bladder cancer (English)

1 reference

1 September 2017

2 references

7 August 2019

29 May 2020

1 reference

7 August 2019

Jahan Miremami

1

1 reference

PMCID

4284796

1 September 2017

Natasha Kyprianou

series ordinal

2

1 reference

PMCID

4284796

1 September 2017

language of work or name

English

0 references

publication date

22 December 2014

6 references

International Journal of Molecular Sciences

1 September 2017

3 April 2019

22 April 2019

19 June 2019

7 August 2019

29 May 2020

5 references

1 September 2017

3 April 2019

22 April 2019

19 June 2019

7 August 2019

15

1 reference

1 September 2017

12

1 reference

1 September 2017

23897-23908

1 reference

Creative Commons Attribution

1 September 2017

4 references

3 April 2019

22 April 2019

19 June 2019

7 August 2019

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Urinary markers for bladder cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Essentials of circulating tumor cells for clinical research and practice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Detecting circulating tumor cells: current challenges and new trends

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Economic aspects of bladder cancer: what are the benefits and costs?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Economic impact of tumor markers in bladder cancer surveillance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Considerations on the use of diagnostic markers in management of patients with bladder cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

The health economics of bladder cancer: a comprehensive review of the published literature.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Menage a Trois: intimate relationship among a microRNA, long noncoding RNA, and mRNA.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Predicting progression of bladder urothelial carcinoma using microRNA expression

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4284796

The prognostic value of P-cadherin in non-muscle-invasive bladder cancer

31 August 2018

1 reference

12 December 2020

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis

1 reference

12 December 2020

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS151223897

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

PMCID

4284796